INAVA and breast carcinoma: Our C1orf106 expression analysis in these lines corroborates findings from gene expression analysis of human breast cancer tumours, indicating that C1orf106 is expressed at higher levels in more aggressive basal and triple-negative subtypes (Figure 3).